Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

BACKGROUND: There are few data on tuberculosis (TB) incidence in HIV-infected children on antiretroviral therapy (ART). Observational studies suggest co-trimoxazole prophylaxis may prevent TB, but there are no randomized data supporting this. The ARROW trial, which enrolled HIV-infected children ini...

Full description

Bibliographic Details
Main Authors:	Crook, A, Turkova, A, Musiime, V, Bwakura-Dangarembizi, M, Bakeera-Kitaka, S, Nahirya-Ntege, P, Thomason, M, Mugyenyi, P, Musoke, P, Kekitiinwa, A, Munderi, P, Nathoo, K, Prendergast, A, Walker, A, Gibb, D, ARROW Trial Team
Format:	Journal article
Language:	English
Published:	BioMed Central 2016

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.

Similar Items